Brown Advisory Inc. Has $518,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Brown Advisory Inc. decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 11.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,912 shares of the company’s stock after selling 254 shares during the quarter. Brown Advisory Inc.’s holdings in HCA Healthcare were worth $518,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Stone House Investment Management LLC bought a new position in HCA Healthcare in the 3rd quarter valued at $25,000. Centerpoint Advisors LLC bought a new position in HCA Healthcare in the 4th quarter valued at $27,000. Atlantic Edge Private Wealth Management LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $27,000. Bruce G. Allen Investments LLC bought a new stake in shares of HCA Healthcare during the fourth quarter worth $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC bought a new stake in shares of HCA Healthcare during the third quarter worth $30,000. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

HCA has been the subject of a number of recent research reports. Raymond James boosted their target price on HCA Healthcare from $300.00 to $330.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Barclays lifted their price objective on HCA Healthcare from $356.00 to $367.00 and gave the stock an “overweight” rating in a research note on Monday, April 29th. Royal Bank of Canada lifted their price objective on HCA Healthcare from $322.00 to $329.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. TD Cowen decreased their price objective on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research note on Tuesday, April 30th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research note on Friday, April 12th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $317.00.

HCA Healthcare Stock Up 1.1 %

HCA stock opened at $318.70 on Monday. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The stock has a market capitalization of $83.47 billion, a P/E ratio of 15.89, a P/E/G ratio of 1.48 and a beta of 1.66. The business has a 50-day moving average of $318.89 and a 200-day moving average of $305.81. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The company had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $16.81 billion. During the same period in the prior year, the firm earned $4.93 earnings per share. HCA Healthcare’s revenue for the quarter was up 11.2% compared to the same quarter last year. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 20.84 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare declared that its Board of Directors has authorized a share buyback program on Tuesday, January 30th that permits the company to buyback $6.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 7.4% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Insider Buying and Selling

In related news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total transaction of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the sale, the senior vice president now owns 19,612 shares in the company, valued at $6,397,042.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Chad J. Wasserman sold 344 shares of the company’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $321.97, for a total value of $110,757.68. Following the completion of the sale, the senior vice president now owns 2,452 shares in the company, valued at approximately $789,470.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 13,617 shares of company stock worth $4,321,986. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.